Ergoteles LLC Krystal Biotech, Inc. Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$72.39 - $84.27 $121,108 - $140,983	1,673 Added 11.86%	15,781 $1.26 Million
Q4 2022 Feb 14, 2023	BUY	$63.14 - $79.9 $890,779 - $1.13 Million	14,108 New	14,108 $1.12 Million
Q1 2022 May 13, 2022	SELL	$51.99 - $72.11 $883,933 - $1.23 Million	-17,002 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$39.81 - $88.24 $676,849 - $1.5 Million	17,002 New	17,002 $1.19 Million

309

24.3M

483K

364K

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $3.92B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.